Erythropoiesis-stimulating Agent [EPC]

67878 reported adverse events

Drugs of this class: EPOETIN ALFA-EPBX DARBEPOETIN ALFA EPOETIN ALFA ERYTHROPOIETIN

These side effects are most commonly reported by patients taking drugs of the Erythropoiesis-stimulating Agent [EPC] class:

# Side effect Count
0 DEATH 17088
1 HOSPITALISATION 6137
2 ANAEMIA 3261
3 HAEMOGLOBIN DECREASED 2956
4 FATIGUE 2671
5 OFF LABEL USE 2463
6 DYSPNOEA 2337
7 DIARRHOEA 2224
8 ASTHENIA 2116
9 NAUSEA 2116
See all common reactions for Erythropoiesis-stimulating Agent [EPC]

Drugs of the Erythropoiesis-stimulating Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 210 0.8898
1 ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE 41 0.7455
2 ARTERIOVENOUS FISTULA SITE COMPLICATION 250 0.4638
3 APLASIA PURE RED CELL 1046 0.4393
4 PEAU D'ORANGE 32 0.3478
5 SKIN FIBROSIS 129 0.3079
6 RETICULOCYTE COUNT DECREASED 92 0.2813
7 PERITONEAL DIALYSIS 189 0.2755
8 ARTERIOVENOUS FISTULA SITE INFECTION 31 0.2650
9 ARTERIOVENOUS FISTULA OPERATION 54 0.2559
See all enriched reactions for Erythropoiesis-stimulating Agent [EPC]